We are live on ! Find out more
HAIM

Hunter Associates Investment Management Portfolio holdings

AUM $868M
1-Year Est. Return 32.25%
This Fund
S&P 500
This Quarter Est. Return
+3.8%
1 Year Est. Return
+32.25%
3 Year Est. Return
+76.06%
5 Year Est. Return
+90.53%
10 Year Est. Return
+362.05%
AUM
$238M
AUM Growth
+$3.39M
Cap. Flow
-$3.68M
Cap. Flow %
-1.55%
Top 10 Hldgs %
30.82%
Holding
164
New
8
Increased
30
Reduced
66
Closed
3

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$1.45M
2
PG icon
Procter & Gamble
PG
+$1.01M
3
AMGN icon
Amgen
AMGN
+$509K
4
IBM icon
IBM
IBM
+$451K
5
TROW icon
T. Rowe Price
TROW
+$435K

Sector Composition

Rank Sector Weight
1 Healthcare 24.26%
2 Technology 21.27%
3 Industrials 14.77%
4 Consumer Staples 9.04%
5 Energy 8.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MMM icon
1
3M
MMM
$90.9B
$10.4M 4.39%
65,196
-1,866
-3% -$286K
AMGN icon
2
Amgen
AMGN
$208B
$9.64M 4.05%
58,738
-3,065
-5% -$509K
MSFT icon
3
Microsoft
MSFT
$3.45T
$8.73M 3.67%
132,587
-5,302
-4% -$340K
JNJ icon
4
Johnson & Johnson
JNJ
$618B
$8.1M 3.41%
65,065
-1,475
-2% -$176K
XOM icon
5
ExxonMobil
XOM
$644B
$7.44M 3.13%
90,682
-4,807
-5% -$402K
AAPL icon
6
Apple
AAPL
$4.54T
$6.57M 2.76%
182,948
-4,360
-2% -$144K
TROW icon
7
T. Rowe Price
TROW
$23.9B
$5.84M 2.46%
85,674
-6,130
-7% -$435K
RMD icon
8
ResMed
RMD
$30.6B
$5.7M 2.4%
79,151
-600
-0.8% -$41.5K
FISV
9
Fiserv Inc
FISV
$28.8B
$5.55M 2.33%
96,234
-7,314
-7% -$411K
PFE icon
10
Pfizer
PFE
$143B
$5.27M 2.22%
162,235
-45,865
-22% -$1.45M
PEP icon
11
PepsiCo
PEP
$190B
$5.17M 2.18%
46,230
-1,975
-4% -$212K
WY icon
12
Weyerhaeuser
WY
$18B
$5.1M 2.15%
150,170
+56,270
+60% +$1.83M
PG icon
13
Procter & Gamble
PG
$336B
$4.87M 2.05%
54,227
-11,433
-17% -$1.01M
ACN icon
14
Accenture
ACN
$102B
$4.59M 1.93%
38,268
-1,070
-3% -$128K
CSCO icon
15
Cisco
CSCO
$457B
$4.58M 1.93%
135,524
-3,952
-3% -$128K
UPS icon
16
United Parcel Service
UPS
$88.6B
$4.5M 1.89%
41,975
OFLX icon
17
Omega Flex
OFLX
$297M
$4.49M 1.89%
94,028
-5,199
-5% -$246K
INTC icon
18
Intel
INTC
$455B
$4.28M 1.8%
118,698
-1,742
-1% -$63K
BOOM icon
19
DMC Global
BOOM
$138M
$3.98M 1.67%
320,587
-2,300
-0.7% -$34.5K
CELG
20
DELISTED
Celgene Corp
CELG
$3.58M 1.51%
28,753
-100
-0.3% -$12K
GE icon
21
GE Aerospace
GE
$374B
$3.56M 1.5%
24,929
-268
-1% -$38.8K
GILD icon
22
Gilead Sciences
GILD
$162B
$3.56M 1.5%
52,388
+3,170
+6% +$223K
IBM icon
23
IBM
IBM
$211B
$3.49M 1.47%
20,956
-2,691
-11% -$451K
EV
24
DELISTED
Eaton Vance Corp.
EV
$3.37M 1.42%
74,945
-250
-0.3% -$11.1K
LH icon
25
Labcorp
LH
$25B
$3.17M 1.33%
25,712
-1,164
-4% -$138K

Similar funds

Hunter Associates Investment Management's Q1 2017 Portfolio in Review

As of Q1 2017, Hunter Associates Investment Management held 164 positions worth $238M, up 1.4% from $234M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Hunter Associates Investment Management's Q1 2017 filing shows 8 new, 30 increased, 66 reduced and 3 closed positions. Its largest new stake was Endo International plc: 33,900 shares worth $378K. The largest sale was Pfizer, an estimated $1.45M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 24% a quarter earlier, followed by Technology and Industrials.

  • Hunter Associates Investment Management's largest Q1 2017 buy was Endo International plc: 33,900 shares worth $378K.
  • Hunter Associates Investment Management added most to Weyerhaeuser in Q1 2017, an estimated $1.83M increase.
  • Hunter Associates Investment Management's biggest Q1 2017 reduction was Pfizer, cutting an estimated $1.45M.
  • Hunter Associates Investment Management fully exited NextGen Healthcare, Inc. Common Stock in Q1 2017, selling an estimated $263K.
  • Hunter Associates Investment Management's ten largest holdings make up 31% of its $238M portfolio in Q1 2017.
  • Hunter Associates Investment Management opened 8 new positions and closed 3 in Q1 2017.
  • Hunter Associates Investment Management's portfolio value rose 1.4% quarter-over-quarter to $238M.

Based on Hunter Associates Investment Management's 13F filing for Q1 2017, filed 10 May 2017.